We thus here re-evaluated the expression level of YBX3 as well as other genes implicated in ccRCC in a larger panel of ccRCC samples (16 instead of 5 previously used), each compared to adjacent non tumoral tissue, and evaluated 8 different HKGs to select for best reference. This evidence concerns the gene YBX3 and nonpapillary renal cell carcinoma.